Otago Innovation Limited
12 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
1
Ending by 2030
Aug 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 4, 2027The maintenance fee for Quinoline Sulfonamide Compounds and Their Use as Antibacterial Agents (US 11,691,949) comes due Jan 4, 2027. Unpaid by Jul 6, 2027, it lapses early.
- 1 fee due Feb 28, 2027The maintenance fee for Pharmaceutical Combinations and Methods for the Treatment of Diabetes and Associated Disorders (US 11,738,001) comes due Feb 28, 2027. Unpaid by Aug 30, 2027, it lapses early.
- 1 fee due Jun 3, 2027The maintenance fee for Carbon monoxide releasing norbornenone compounds (US 10,494,344) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 8 of 8
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,809,301 | Surgical Hydrogel In force · High confidence | In force | High confidence | |
| US 10,494,344 | Carbon monoxide releasing norbornenone compounds In force · USPTO record | In force | USPTO record | |
| US 11,072,584 | Carbon monoxide releasing norbornenone compounds In force · USPTO record | In force | USPTO record | |
| US 10,995,186 | Light-activated preparation of hydrogels In force · USPTO record | In force | USPTO record | |
| US 11,691,949 | Quinoline Sulfonamide Compounds and Their Use as Antibacterial Agents In force · High confidence | In force | High confidence | |
| US 10,763,966 | Data communications system using an optical antenna In force · USPTO record | In force | USPTO record | |
| US 11,738,001 | Pharmaceutical Combinations and Methods for the Treatment of Diabetes and Associated Disorders In force · High confidence | In force | High confidence | |
| US 12,077,495 | Compounds for the Treatment of Acute Brain Injury In force · High confidence | In force | High confidence |
Also on record, not counted in the 8: 12 patents in force now held by others · 18 lapsed for an unpaid fee · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending · 1 abandoned · 15 no status recorded